Dr. Elias Jabbour graduated from the Saint Joseph’s School of Medicine in 1998 and joined, thereafter, the Hotel Dieu de France University Hospital as a resident. In 2001, he pursued in fellowship in Hematology-Oncology at the Gustave Roussy Institute. In 2003, he joined the University of Texas M. D. Anderson Cancer as a fellow in the Department of Hematology/Leukemia and Stem cell transplantation. Thereafter, in 2007, he joined the faculty in the Leukemia department as Assistant Professor.
Dr. Jabbour is actively involved in research in both acute and chronic forms of leukemia. He was actively involved in clinical trials that lead to the approval of several drugs in chronic myeloid leukemia (CML) and myelodysplastic syndromes. His research on resistance to imatinib and mutations of the protein kinase domain were presented in several international; meetings and published in peer-reviewed journals. He is also developing tailored therapies to CML.
Dr. Jabbour has taken an active role in the medical community, participating in numerous scientific meetings. He has authored or co-authored numerous publications and abstracts and serves as a reviewer for many scientific journals. In 2005, 2006, and 2007, he received the American Society of Clinical Oncology and the American Society of Hematology merit awards for Outstanding Clinical fellow, in addition to two similar awards from the American Society of Bone Marrow Transplantation. Due to Dr. Jabbour’s commitment and hard work he was promoted to Associate
Professor in September 2013.